Latest information on COVID-19
Support teaching, research, and patient care.
My research is in neuroimmunology. I attend on the inpatient service at LPCH.
Our laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.
Biobank For MS And Other Demyelinating Diseases
To establish a large, longitudinal collection of high quality samples and data from subjects
with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis
Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis
(ON)), and related and unrelated unaffected controls. Samples and data will be available as a
shared resource to scientists researching the causes, sub-types, and biomarkers of MS and
related demyelinating diseases.
Stanford is currently not accepting patients for this trial.
For more information, please contact Lawrence Steinman, .
View full details